ALEXIA ROWLEY: Open Payments
NPI 1588085930 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,279 in 66 payments from 18 companies in 2025. Trend: 2023 $420 · 2024 $792 · 2025 $2,279
Food & beverage: $1,559Consulting: $630Education: $90
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $958 |
| GlaxoSmithKline, LLC. | 18 | $353 |
| Regeneron Healthcare Solutions, Inc. | 11 | $277 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Insmed, Inc. | 5 | $89 |
| ANI Pharmaceuticals, Inc. | 3 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56 |
| United Therapeutics Corporation | 2 | $52 |
| Verona Pharma, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $40 |
Products named: DUPIXENT, NUCALA, Arikayce, PURIFIED CORTROPHIN GEL, OFEV, Tyvaso, TRELEGY ELLIPTA, Ohtuvayre.
Industry payments across TX — which companies pay providers there.
